Fri.Mar 01, 2024

article thumbnail

With Sanofi left as the lone supplier of tetanus shots in the US, CDC warns of shortage

Fierce Pharma

It’s time to add another vaccine to the shortage list in the U.S. | It’s time to add another vaccine to the shortage list in the United States as the CDC has urged healthcare providers to conserve their supply of tetanus shots. The warning from the national public health agency comes after one of the two providers of tetanus shots in the U.S., MassBiologics, discontinued production of its tetanus and diphtheria vaccine.

article thumbnail

Pfizer’s new cancer unit sees eight new blockbusters by 2030

pharmaphorum

Pfizer says new oncology division will generate eight new blockbusters by 2030, in first R&D update after its $43bn takeover of Seagen.

124
124
article thumbnail

Moderna lays off parts of manufacturing team after resizing COVID footprint

Fierce Pharma

Moderna is laying off employees within its manufacturing unit, with the move tied to a resizing of its COVID production work. | Moderna is laying off some employees within its manufacturing unit after shaving COVID production costs. The company previously disclosed plans to rightsize its COVID vaccine production footprint.

article thumbnail

Inside One Organization’s Efforts To Create the First National Pharmacy Union

MedCity News

The Pharmacy Guild recently launched and aims to create the first national pharmacy union in the U.S. But it has a difficult road ahead going up against giants like Walgreens and CVS. Still, its organizers expect the union to be successful.

114
114
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

After PhRMA loss, AstraZeneca's challenge to IRA price negotiations is rejected

Fierce Pharma

Less than three weeks after a Texas judge tossed a lawsuit b | Less than three weeks after a Texas judge tossed a lawsuit by industry lobbying group PhRMA that challenged the constitutionality of the Inflation Reduction Act, a federal court in Delaware has done the same with a similar action brought by AstraZeneca.

208
208
article thumbnail

4SC files maintenance CTCL therapy Kinselby in EU

pharmaphorum

German biotech 4SC has filed its oral HDAC inhibitor Kinselby as a maintenance therapy for rare cancer CTCL in the EU

107
107

More Trending

article thumbnail

Researchers reveal COVID-19 could have small impacts on cognition and memory

PharmaTimes

Different factors, such as illness duration and virus variant, impacted patients cognitive abilities

Patients 106
article thumbnail

CAR-T boxed warnings: What comes next?

Fierce Pharma

The FDA recently asked the six marketed CAR-T therapies to add a new boxed warning item on their labels to reflect the risk of secondary T-cell cancers. | The FDA recently asked the six marketed CAR-T therapies to add a new boxed warning item on their labels to reflect the risk of secondary T-cell cancers. This week on "The Top Line," Fierce Pharma’s Angus Liu talks with regulatory experts to understand the rationale behind the FDA’s decision and to discuss its implications for CAR-T c

FDA 174
article thumbnail

New film aims to raise awareness of rare disease cALD

pharmaphorum

Rare Disease Day saw the debut of a film that aims to raise awareness of cerebral adrenoleukodystrophy (cALD), a devastating and fatal condition with no pharmacological treatments available.

article thumbnail

As Imbruvica stumbles, BeiGene's Brukinsa steps up with FDA nod in follicular lymphoma

Fierce Pharma

With a new FDA nod, BeiGene has filled the follicular lymphoma approval gap for BTK inhibitors. | BeiGene has filled the follicular lymphoma gap for BTK inhibitors with an FDA approval for Brukinsa about a year after AbbVie and Johnson & Johnson's Imbruvica stumbled in a phase 3 trial. But tough competition with CAR-T therapies and bispecifics lies ahead.

FDA 170
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Biotech funding optimism rises as 44% predict recovery in 2024

Pharmaceutical Technology

During 2023, funding decreased by 43.2% compared to 2022 and by 52.3% compared to 2021, attributed to macroeconomic pressures.

104
104
article thumbnail

Ahead of strategy reveal, Bayer taps activist investor Jeffrey Ubben for board seat

Fierce Pharma

In the latest shake-up amid waves of changes at Bayer, the company is planning to add new expertise to its board room, including a prominent activist investor. | The company's supervisory board proposed the appointments of activist investor Jeffrey Ubben, legal expert Lori Schecter and biotech leader Nancy Simonian, M.D. Bayer also swapped in a new head of its consumer health division.

169
169
article thumbnail

WebMD Bolsters Patient Engagement Offerings Through New Acquisition

MedCity News

WebMD acquired the operating assets of Healthwise, a nonprofit provider of health education content and patient engagement tools. The deal follows another acquisition WebMD made in the patient engagement space in 2020. According to Ann Bilyew, WebMD’s senior vice president of health, the company is now “the indisputable market leader in providing patient education to both providers and payers.

Patients 104
article thumbnail

MHRA okays first drug under new mutual recognition scheme

pharmaphorum

A new formulation of Amgen’s cancer treatment Xgeva is the first to be approved in the UK under a new procedure designed to speed up access to new therapies.

102
102
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

Getting a Grip on Ballooning Healthcare Data

MedCity News

The benefits of healthcare data are undeniable—more informed decisions, better diagnoses, enhanced operational efficiency, improved patient satisfaction—but all that data also creates significant challenges.

article thumbnail

ICL uses AI to help doctors assess lung cancer from ‘virtual biopsies’

PharmaTimes

TMR-CT will help doctors select treatment and predict the spread of lung cancer in patients

Doctors 101
article thumbnail

Cancer Biotech Lands $145M for First-in-Class Drug to Block Elusive Tumor Target

MedCity News

FogPharma’s lead program is a peptide that blocks a difficult-to-drug pathway inside of cells. The new financing will go toward an ongoing Phase 1/2 study in advanced solid tumors and support development of pipeline programs for other elusive cancer targets.

Leads 100
article thumbnail

2024 Pharmaceutical industry trends – discover the latest pharma quality and manufacturing trends

European Pharmaceutical Review

Technology trends Current technology trends are influencing consumer behaviour and reshaping the way industry operates. Although pharma companies are working steadily to leverage the power of data and become more agile and resilient, there is still room for improvement. The post 2024 Pharmaceutical industry trends – discover the latest pharma quality and manufacturing trends appeared first on European Pharmaceutical Review.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Navigating the Wellness Frontier: Show Me the Science

MedCity News

Wellness-oriented consumers are seeking products and practices backed not only by promises but by scientific credibility.

article thumbnail

New antibody drug formulation wins novel MHRA approval

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the first product via its new International Recognition Procedure (IRP). The approval was for a new formulation for XGEVA (denosumab), to prevent serious bone-related complications caused by bone metastasis in adults and to treat giant cell tumour of bone in adults and adolescents.

article thumbnail

Green granulation: Tracking energy efficiency in pharmaceutical granulation

Pharmaceutical Technology

Experts say that dry granulation is 10x more efficient than wet granulation, which could make substantial progress towards making this pharmaceutical process greener.

article thumbnail

Joint investment to accelerate UK sustainable biomanufacturing

European Pharmaceutical Review

A new £11.5 million investment is set to support the development of innovative solutions to drive advancements in sustainable biomanufacturing in the UK. The UK Research and Innovation ( UKRI ) is backing 21 cross-sector collaborations designed to generate innovation, commercialisation and growth in this area. UKRI highlighted that overall, these investments will “enhance the UK’s global competitiveness by supporting research and innovation that leads to new and disruptive biomanufacturing proce

article thumbnail

Signal-Based Selling: How to Leverage 4 Key Buying Signals

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

article thumbnail

Safely Navigating the Multi-Cloud Security Landscape: Strategies for Protecting Data Integrity in Healthcare

MedCity News

A surge in cloud adoption by healthcare organizations brings new challenges, particularly in safeguarding data across diverse providers while meeting regulatory frameworks.

article thumbnail

Clinical Trial Protocol Conceptualization: A Customer Story

Impetus Digital

To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical and early Phase I data and proposed protocol, from three parallel groups comprising oncologists, oncology nurses, and patients. For each group, we executed three virtual touchpoints.

article thumbnail

StartUPDATES: New developments from healthcare startups

MedCity News

Check out news from Alpha Sophia, Abridge, Baseimmune, Carewell, and Redi Health.

article thumbnail

European Pharmaceutical Review Issue 1 2024

European Pharmaceutical Review

Articles included in Issue 1 of European Pharmaceutical Review include: FOREWORD Validation of analytical procedures – ICH Q2(R2) David Elder, David P Elder Consultancy REGULATORY INSIGHT The EU pharmaceutical reform: tweaks to marketing authorisation procedures Vladimir Murovec, Osborne Clarke SEPARATION & PURIFICATION IDF Fractionation, purification and downstream processing: the path to commercialisation Rob Abbenhuis, Ardena PAT Process analytics for the new era of continuous RNA manufac

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Balancing Health Tech Innovation With Safety: Navigating the Intersection of AI and Patient Care

Pharmacy Times

Although regulation takes time, real safety concerns for patients in the rapid development of AI technology in health care are present today.

Safety 64
article thumbnail

Panama updates their medicine regulatory system

Pharmaceutical Technology

Panama’s government expects to be a pioneer in the area through the centralisation of drug procurement with an emphasis on pharmacovigilance.

article thumbnail

Forward-thinking CDMO tackles the dynamic challenge of N-nitrosamines control with high-performance analytical instrumentation

European Pharmaceutical Review

API method development and testing at Polpharma API As a key player in the Polish pharmaceutical market and a prominent drug manufacturer in Central and Eastern Europe, Polpharma API exports medicinal products to 35 markets and active pharmaceutical ingredients (APIs) to over 60 countries. Its API manufacturing facilities undergo stringent inspections from regulatory authorities such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

article thumbnail

After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections

PharmaVoice

Impatience to fix long-held challenges to overseas drug facility inspections is growing on Capitol Hill.

FDA 59
article thumbnail

Activating Intent Data for Sales and Marketing

Sales and marketing leaders have reached a tipping point when it comes to using intent data — and they’re not looking back. More than half of all B2B marketers are already using intent data to increase sales, and Gartner predicts this figure will grow to 70 percent. The reason is clear: intent can provide you with massive amounts of data that reveal sales opportunities earlier than ever before.